Answers are grounded in this paper and cite their sources.
HER3-directed therapies are advancing clinically, increasing the possibility that patients of childbearing age, including those diagnosed with cancer during pregnancy, may be exposed to these agents. However, HER3 expression at the human amniotic interface and the interactions of HER3-directed agents with primary amniotic epithelial cells (hAECs) remain poorly understood. We therefore characterized HER3 expression in human amniotic tissues and cells and evaluated the interaction of primary human amniotic epithelial cells with HER3-directed nanobioparticles. Placentas obtained following uncomplicated term deliveries were used to isolate primary hAECs and prepare amniotic membrane and umbilical cord sections. HER3 expression was evaluated in tissues, cells, and hAEC-derived extracellular-vesicle-enriched preparations using multiplex immunofluorescence, flow cytometry, and immunoblotting. A HER3-directed HPK nanobioparticle was characterized and evaluated for its effects on hAEC viability. Nanobioparticle uptake, extracellular release, intracellular trafficking, and transport across hAEC monolayers were examined using pulse-chase analysis, time-resolved imaging, and Transwell assays with concurrent barrier-integrity measurements. Primary hAECs maintained an epithelial morphology and expressed HER3, which was predominantly localized to the amniotic epithelial layer and enriched in vascular regions of the umbilical cord. HER3 was also detected in hAEC-derived extracellular-vesicle-enriched preparations. The HPK nanobioparticles formed nanoscale structures and did not reduce hAEC viability over the tested concentration range. hAECs internalized the nanobioparticles, which underwent transient trafficking through endosomal compartments followed by concentration- and time-dependent extracellular release. Transwell studies further showed time- and temperature-sensitive apical-to-basolateral passage across intact hAEC monolayers without detectable disruption of barrier integrity, consistent with a cellular contribution to transmonolayer transport. Human amniotic and umbilical cord tissues and primary hAECs express HER3, which was also detected in hAEC-derived extracellular-vesicle-enriched preparations. hAECs interacted dynamically with HPK nanobioparticles through cellular uptake, intracellular trafficking, extracellular release, and transmonolayer transport under the tested in vitro conditions. Our findings identify the human amniotic epithelium as a previously unrecognized interface for HER3-directed agents and support further evaluation of their disposition, safety, and potential delivery applications during pregnancy in more physiologically complete placental models.
No takes yet. Share an insight, caveat, or question.
Babajani et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: